{"data":[{"accessionNo":"0001493152-26-043112","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock","eventDate":"2026-09-15","reportingPerson":"Hamid Khoja","reportingCik":"0002010662","personType":"IN","sharesOwned":630009,"percentOfClass":7.5,"filedAt":"2026-09-17"},{"accessionNo":"0001172661-26-003577","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-06-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":738977,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0001172661-26-003577","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-06-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":738977,"percentOfClass":9.99,"filedAt":"2026-08-14"},{"accessionNo":"0000929638-26-001441","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-04-02","reportingPerson":"Lind Global Fund III LP","reportingCik":null,"personType":"PN","sharesOwned":230234,"percentOfClass":4.99,"filedAt":"2026-04-09"},{"accessionNo":"0000929638-26-001441","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-04-02","reportingPerson":"Lind Global Partners III LLC","reportingCik":null,"personType":"CO","sharesOwned":230234,"percentOfClass":4.99,"filedAt":"2026-04-09"},{"accessionNo":"0000929638-26-001441","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001958777","issuerName":"FibroBiologics, Inc.","ticker":"FBLG","cusip":"31573L204","securityClass":"Common Stock, $0.00001 par value","eventDate":"2026-04-02","reportingPerson":"EASTON JEFF","reportingCik":null,"personType":"IN","sharesOwned":230234,"percentOfClass":4.99,"filedAt":"2026-04-09"}],"updatedAt":"2026-09-19T07:06:19.774Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data"}